CALGARY, March 1, 2019 /CNW/ - (TSXV/CSE: TCI) Target
Capital Inc. d.b.a. CBi2
Capital ("CBi2" or
the "Corporation") is pleased to provide a summary of
its financial results for the financial quarter ended December 31, 2018.
Selected financial information is outlined below and should be
read in conjunction with the Corporation's consolidated financial
statements ("Financial Statements") and management's
discussion and analysis ("MD&A") for the financial
quarter ended December 31, 2018,
which are available on SEDAR at www.sedar.com and the Corporation's
website at www.cbi2.com.
Financial Highlights
The following table summarizes key financial highlights
associated with the Corporation's financial performance.
|
December 31,
2018
$000s
|
|
December 31,
2017
$000s
|
|
Revenues
|
409
|
|
467
|
|
Expenses
|
914
|
|
382
|
|
Net
Income/(Loss)
|
(505)
|
|
85
|
|
Total
Assets
|
3,803
|
|
4,662
|
|
Total
Liabilities
|
79
|
|
88
|
|
Total Shareholders'
Equity (Deficit)
|
3,724
|
|
4574
|
The financial quarter ended December 31,
2018 was a transformative year for the Corporation. The
transactions that were completed had a significant impact on the
comparability of the Corporation's period over period results. See
the Financial Statements and MD&A for further details.
About CBi2 Capital
Target Capital Inc., d.b.a. CBi2 Capital, is a
Calgary, Alberta based company
engaged in making strategic investments in private companies,
including small start‐up operations and land development companies.
The Corporation's common shares are listed on the TSX Venture
Exchange and the Canadian Securities Exchange under the trading
symbol "TCI". CBi2 is executing on a cannabis-focused
investment strategy, where it intends to develop and manage a
diversified portfolio of predominantly early stage cannabis
investment opportunities. CBi2 will explore and invest
in a number of strategic investment opportunities in the medical
and recreational cannabis industry and in businesses offering
ancillary supportive products and services.
Forward-Looking and Cautionary Statements
This news release may include forward-looking statements
including CBi2 's objectives, opinions and assumptions. When used
in this document, the words "will," "anticipate," "believe,"
"estimate," "expect," "intent," "may," "project," "should," and
similar expressions are intended to be among the statements that
identify forward-looking statements.
The forward-looking statements are founded on the basis of
expectations and assumptions made by CBi2. Forward-looking
statements are subject to a wide range of risks and uncertainties,
and although CBi2 believes that the expectations represented by
such forward-looking statements are reasonable, there can be no
assurance that such expectations will be realized.
Any number of important factors could cause actual results to
differ materially from those in the forward -looking statements
including, but not limited to: regulatory and third party approvals
not being obtained in the manner or timing anticipated; the ability
to implement corporate strategies; the state of domestic capital
markets; the ability to obtain financing; changes in general market
conditions; industry conditions and events; the size of the medical
marijuana market and the recreational marijuana market; government
regulations, including future legislative and regulatory
developments involving medical and recreational marijuana;
competition from other industry participants; and other factors
more fully described from time to time in the reports and filings
made by CBi2 with securities regulatory authorities.
Except as required by applicable laws, CBi2 does not
undertake any obligation to publicly update or revise any
forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this news release.
SOURCE CBi2 Capital